Show simple item record

dc.contributor.authorMalik, A
dc.contributor.authorLamarca, Angela
dc.contributor.authorSiriwardena, A
dc.contributor.authorO'Reilly, Derek
dc.contributor.authorDeshpande, R
dc.contributor.authorSatyadas, T
dc.contributor.authorJamdar, S
dc.contributor.authorSheen, A
dc.contributor.authorMcNamara, Mairead G
dc.contributor.authorHubner, Richard A
dc.contributor.authorValle, Juan W
dc.contributor.authorCarino, N
dc.date.accessioned2019-04-29T09:48:56Z
dc.date.available2019-04-29T09:48:56Z
dc.date.issued2019en
dc.identifier.citationMalik A, Lamarca A, Siriwardena A, O'Reilly D, Deshpande R, Satyadas T, et al. Is age a barrier to receiving adjuvant chemotherapy for pancreatic ductal adenocarcinoma? Br J Surg. 2019;106:13.en
dc.identifier.urihttp://hdl.handle.net/10541/621754
dc.language.isoenen
dc.titleIs age a barrier to receiving adjuvant chemotherapy for pancreatic ductal adenocarcinoma?en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Hepatobiliary and Pancreatic Surgery, Manchester Royal Infirmaryen
dc.identifier.journalBritish Journal of Surgeryen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record